A gift to the Surgical Oncology Program helps us discover new treatments and cures.
Andrew H. Ko, M.D. specializes in the treatment of malignancies of the gastrointestinal tract, including esophageal, stomach, colorectal, pancreatic, and hepatobiliary cancers. Dr. Ko graduated magna cum laude from Brown University and received his medical degree from Johns Hopkins School of Medicine. After an internship and residency at Beth Israel Hospital in Boston, he completed a fellowship in medical oncology at Stanford University before joining the UCSF faculty in 2001.
Dr. Ko regularly presents patient cases at the Thoracic Oncology and GI Tumor Boards. He is a frequent lecturer in the GI cancer field and has served as Principal Investigator for trials using novel agents in esophageal and GI cancers. Dr. Ko holds memberships in numerous professional organizations and is a member of the Protocol Review and Data and Safety Monitoring committees at UCSF.
Members of UCSF's Gastrointestinal (GI) Oncology
group are the inaugural recipients of the Helen Diller Family
Quality Award, an honor that recognizes exceptional commitment to
providing superior patient care. The group, led by gastrointestinal
cancer expert Alan Venook, MD, was named the top
performer in the UCSF Helen Diller Family Comprehensive Cancer
Center's quality initiative, a pilot project launched in 2007.